Overall INTS gets a fundamental rating of 2 out of 10. We evaluated INTS against 525 industry peers in the Biotechnology industry. The financial health of INTS is average, but there are quite some concerns on its profitability. INTS is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

In the past year INTS has reported negative net income.
INTS had a negative operating cash flow in the past year.
INTS had negative earnings in each of the past 5 years.
In the past 5 years INTS always reported negative operating cash flow.

1.2 Ratios

The Return On Assets of INTS (-122.44%) is worse than 78.86% of its industry peers.
The Return On Equity of INTS (-162.50%) is worse than 65.33% of its industry peers.

		Industry Rank	Sector Rank
ROA	-122.44%
ROE	-162.5%
ROIC	N/A

ROA(3y)-280.06%

ROA(5y)-210.19%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for INTS so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The number of shares outstanding for INTS has been increased compared to 1 year ago.
There is no outstanding debt for INTS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

INTS has an Altman-Z score of -8.37. This is a bad value and indicates that INTS is not financially healthy and even has some risk of bankruptcy.
INTS's Altman-Z score of -8.37 is on the low side compared to the rest of the industry. INTS is outperformed by 68.95% of its industry peers.
INTS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	-8.37

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

INTS has a Current Ratio of 3.60. This indicates that INTS is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of INTS (3.60) is comparable to the rest of the industry.
INTS has a Quick Ratio of 3.60. This indicates that INTS is financially healthy and has no problem in meeting its short term obligations.
INTS has a Quick ratio (3.60) which is in line with its industry peers.

		Industry Rank	Sector Rank
Current Ratio	3.6
Quick Ratio	3.6

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 41.12% over the past year.

EPS 1Y (TTM)41.12%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%76%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

INTS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.27% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y70.79%

EPS Next 2Y34.63%

EPS Next 3Y21.44%

EPS Next 5Y15.27%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

INTS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year INTS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.